Akesobio IPO Initiation: The Tough Get Going
Akeso Biopharma Inc (1495016D CH) is a clinical-stage biopharmaceutical company with aims to address global unmet medical needs in oncology,...
463 Views
ECM Weekly (16 Feb 2020) - ThaiBev Brewery, ByteDance, China Bright Culture, Equitas SFB, LIC
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. ECM...
354 Views
Innovent Biologics Placement: Positive Newsflow Bodes Well for Capital Raising
Innovent Biologics is raising USD 270 million to fund its clinical trial and commercialization of Tyvyt (PD-1). We have covered the company's...
434 Views
Alphamab Oncology: Trading Debut, Valuation Scenario Analysis
Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
499 Views
Alphamab Oncology IPO: Valuation Easy to Swallow
Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
534 Views